Cutting the wrong test at the wrong time
At the critical time when our nation has made meaningful and measurable progress against colorectal cancer incidence, threats to reimbursement for colonoscopy screening for Medicare beneficiaries are looming, which may jeopardize the effectiveness of public health strategies to increase screening and prevention of colorectal cancer in the U.S.
New data from the American Cancer Society indicate that colorectal cancer has declined by 30% in just the last decade among those aged 50 …
Cutting the wrong test at the wrong time
